Short answer · Medically reviewed summary · Last updated: 2026-04-06
The standard of care for Rheumatoid Arthritis involves a combination of disease-modifying antirheumatic drugs (DMARDs), biologic agents, and targeted therapies, all tailored to achieve clinical remission or low disease activity. Pharmacological Management Treatment for Rheumatoid Arthritis typically begins with conventional synthetic DMARDs, with methotrexate (Trexall) serving as the anchor therapy. If patients do not achieve their treatment targets, clinicians may introduce biologic DMARDs—such as adalimumab (Humira), etanercept (Enbrel), or infliximab (Remicade)—which target specific inflammatory pathways.
5 people with Rheumatoid Arthritis have shared their first-person experience on this question at DiseaseMaps.
What are the best treatments for Rheumatoid Arthritis?
Treatments for Rheumatoid Arthritis: what real patients say works for them, alongside a medically reviewed overview citing sources like NIH GARD and Orphanet.
The standard of care for Rheumatoid Arthritis involves a combination of disease-modifying antirheumatic drugs (DMARDs), biologic agents, and targeted therapies, all tailored to achieve clinical remission or low disease activity.
Pharmacological Management
Treatment for Rheumatoid Arthritis typically begins with conventional synthetic DMARDs, with methotrexate (Trexall) serving as the anchor therapy. If patients do not achieve their treatment targets, clinicians may introduce biologic DMARDs—such as adalimumab (Humira), etanercept (Enbrel), or infliximab (Remicade)—which target specific inflammatory pathways. Janus kinase (JAK) inhibitors, such as tofacitinib (Xeljanz), represent a class of oral targeted synthetic DMARDs that have become an essential option for managing Rheumatoid Arthritis when biologic therapy fails or is contraindicated.
Non-Pharmacological and Emerging Therapies
Beyond medication, physical therapy and occupational therapy are vital for maintaining joint mobility, preserving function, and developing energy-conservation strategies. Surgery, such as joint replacement, is reserved for patients with advanced joint damage that limits daily life. Research is currently exploring personalized medicine through pharmacogenomics to predict drug response, as well as investigating B-cell depletion therapies and novel immunomodulators in clinical trials to improve outcomes for those with refractory Rheumatoid Arthritis.
The Multidisciplinary Care Team
Because Rheumatoid Arthritis is a systemic autoimmune condition, it requires a multidisciplinary care team. This team is typically led by a rheumatologist and often includes a physical therapist, an occupational therapist, a clinical psychologist to help manage the burden of chronic pain, and an orthopedic surgeon for long-term joint health.
Treatment effectiveness varies significantly between individuals; what works for one patient may not work for another, necessitating a personalized approach directed by your healthcare provider. Please consult your physician before making any changes to your treatment plan.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- American College of Rheumatology (ACR)
- Orphanet: Portal for rare diseases and orphan drugs
Posted May 19, 2017 by Carissa 1100
Posted May 28, 2017 by Carlos Monero 1000
Posted May 28, 2017 by Daniela 1000
Undeterred;
Rest when the body to send;
Be picky with yourself;
Anti-inflammatory medications, type vimovo;
Friends that help you;
People who support you;
Posted May 28, 2017 by Ana 1000
The massage and tratamientosde laser on the affected area, for me are a relief.
Posted Nov 15, 2017 by Pedro 1500
